PMID- 33499235 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210210 IS - 2077-0383 (Print) IS - 2077-0383 (Electronic) IS - 2077-0383 (Linking) VI - 10 IP - 3 DP - 2021 Jan 22 TI - Endothelin A Receptors Expressed in Glomeruli of Renal Transplant Patients May Be Associated with Antibody-Mediated Rejection. LID - 10.3390/jcm10030422 [doi] LID - 422 AB - BACKGROUND: Non-human leukocyte antigen (HLA) anti-endothelin A receptor antibodies are presented as being potentially important, but the expression of the endothelin A receptor in glomeruli (ETA receptor (g+)) has not yet been described. We decided to evaluate the presence and relevance of the ETA receptor in for-cause renal transplant biopsies. The aim of our study was to evaluate the immunoreactivity of the ETA receptor and its significance in patients who underwent a renal transplant biopsy due to the deterioration of transplant function, with detailed characterization of staining in glomeruli. METHODS: The immunohistochemical expression of ETA receptor (ETAR) was analyzed in renal transplant biopsies. Microscopic evaluation was performed on paraffin sections in glomeruli. The analysis was performed using a two-step scale (0: lack of ETAR expression; 1: the presence of ETAR expression-mild to moderate immunoreactivity). RESULTS: We analyzed 149 patients who underwent renal allograft biopsy after renal transplantation. Positive staining of ETA receptors in glomeruli (ETA receptor (g+)) was noticed in 13/149 (8.7%) patients. Five of these 13 (38.5%) patients with ETA receptor (g+) developed antibody-mediated rejection (AMR), while 13 of the remaining 136 (9.5%) ETA receptor (g-) patients developed AMR (p = 0.0022). Graft loss was noticed in all but one ETA receptor (g+) patient with AMR (4/5; 80%), but only in 2/13 (15%) ETA receptor (g-) patients with AMR (p = 0.009) during the first year after biopsy. CONCLUSIONS: The expression of endothelin A receptors in glomeruli seems to be a potentially important feature in the diagnosis of damage during antibody-mediated rejection. It may help to identify patients at a higher risk of allograft rejection and injury. FAU - Nowanska, Katarzyna AU - Nowanska K AD - Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland. FAU - Banasik, Miroslaw AU - Banasik M AD - Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland. FAU - Donizy, Piotr AU - Donizy P AD - Department of Pathomorphology and Oncological Cytology, Wroclaw Medical University, 50-367 Wroclaw, Poland. FAU - Koscielska-Kasprzak, Katarzyna AU - Koscielska-Kasprzak K AD - Research laboratory, Wroclaw Medical University, 50-367 Wroclaw, Poland. FAU - Zmonarski, Slawomir AU - Zmonarski S AD - Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland. FAU - Letachowicz, Krzysztof AU - Letachowicz K AUID- ORCID: 0000-0002-2747-8851 AD - Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland. FAU - Kaminska, Dorota AU - Kaminska D AUID- ORCID: 0000-0003-2400-9328 AD - Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland. FAU - Mazanowska, Oktawia AU - Mazanowska O AUID- ORCID: 0000-0001-7669-7543 AD - Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland. FAU - Augustyniak-Bartosik, Hanna AU - Augustyniak-Bartosik H AUID- ORCID: 0000-0003-3969-396X AD - Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland. FAU - Tukiendorf, Andrzej AU - Tukiendorf A AD - Department of Public Health, Wroclaw Medical University, 50-367 Wroclaw, Poland. FAU - Chudiak, Anna AU - Chudiak A AD - Division of Nursing in Internal Medicine Procedures, Department of Clinical Nursing, Faculty of Health Sciences, Wroclaw Medical University, 50-367 Wroclaw, Poland. FAU - Dawiskiba, Tomasz AU - Dawiskiba T AUID- ORCID: 0000-0003-2329-2918 AD - Department of General, Vascular and Transplant Surgery, Wroclaw Medical University, 50-367 Wroclaw, Poland. FAU - Halon, Agnieszka AU - Halon A AD - Department of Pathomorphology and Oncological Cytology, Wroclaw Medical University, 50-367 Wroclaw, Poland. FAU - Krajewska, Magdalena AU - Krajewska M AD - Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland. LA - eng GR - STM.C160.20.155/The research was financially supported by the Ministry of Health subvention according to number from the IT Simple system of the Wroclaw Medical University./ PT - Journal Article DEP - 20210122 PL - Switzerland TA - J Clin Med JT - Journal of clinical medicine JID - 101606588 PMC - PMC7865600 OTO - NOTNLM OT - allograft injury OT - antibody-mediated rejection OT - endothelin A receptors OT - non-HLA antibodies COIS- The authors declare no conflict of interest. EDAT- 2021/01/28 06:00 MHDA- 2021/01/28 06:01 PMCR- 2021/01/22 CRDT- 2021/01/27 01:08 PHST- 2020/11/24 00:00 [received] PHST- 2021/01/02 00:00 [revised] PHST- 2021/01/18 00:00 [accepted] PHST- 2021/01/27 01:08 [entrez] PHST- 2021/01/28 06:00 [pubmed] PHST- 2021/01/28 06:01 [medline] PHST- 2021/01/22 00:00 [pmc-release] AID - jcm10030422 [pii] AID - jcm-10-00422 [pii] AID - 10.3390/jcm10030422 [doi] PST - epublish SO - J Clin Med. 2021 Jan 22;10(3):422. doi: 10.3390/jcm10030422.